• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与卵巢转移相关的表达CD133的干细胞建立了内皮细胞层级结构并促进肿瘤血管生成。

CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature.

作者信息

Kusumbe Anjali P, Mali Avinash M, Bapat Sharmila A

机构信息

National Centre for Cell Science, NCCS Complex, Pune, India.

出版信息

Stem Cells. 2009 Mar;27(3):498-508. doi: 10.1634/stemcells.2008-0868.

DOI:10.1634/stemcells.2008-0868
PMID:19253934
Abstract

Recruitment and localization of endothelial precursors within tumors is a potential area for the development of therapeutics, because their functional contribution to tumor vasculature is realized to be important for cancer cell survival. However, the exact nature of the recruited cell type and cellular events orchestrating the entire phenomenon remains obscure. We report that human ovarian cancer is frequently associated with cells expressing the stem cell surface marker CD133. We further show that these CD133-expressing cells are nontumorigenic in nature, and they augment tumor development through their vasculogenic potential. This cell population is attracted by cancer stem cells (CSCs) and retains a direct physical association within the CSC-derived spheroids. Our study further delineates the contribution of these vasculogenic CD133(+) stem cells, termed by us as endothelial stem cells (EnSCs) to the developing tumor vasculature during disease progression. In support of their being stem cells, the EnSCs have a capability of establishing an entire endothelial cell hierarchy. We conclude that such EnSCs play a crucial role in ensuring the development of long-term tumor vasculature to complement CSC-driven tumor development and disease progression.

摘要

肿瘤内内皮前体细胞的募集和定位是治疗学发展的一个潜在领域,因为它们对肿瘤血管系统的功能贡献被认为对癌细胞存活很重要。然而,所募集细胞类型的确切性质以及协调整个现象的细胞事件仍不清楚。我们报告,人类卵巢癌常与表达干细胞表面标志物CD133的细胞相关。我们进一步表明,这些表达CD133的细胞本质上是非致瘤性的,并且它们通过其血管生成潜能促进肿瘤发展。这群细胞被癌症干细胞(CSCs)吸引,并在CSC衍生的球体中保持直接的物理关联。我们的研究进一步描述了这些血管生成性CD133(+)干细胞,我们将其称为内皮干细胞(EnSCs)在疾病进展过程中对发育中的肿瘤血管系统的贡献。为支持其作为干细胞的特性,EnSCs具有建立完整内皮细胞层级的能力。我们得出结论,此类EnSCs在确保长期肿瘤血管系统的发育以补充CSC驱动的肿瘤发展和疾病进展方面发挥着关键作用。

相似文献

1
CD133-expressing stem cells associated with ovarian metastases establish an endothelial hierarchy and contribute to tumor vasculature.与卵巢转移相关的表达CD133的干细胞建立了内皮细胞层级结构并促进肿瘤血管生成。
Stem Cells. 2009 Mar;27(3):498-508. doi: 10.1634/stemcells.2008-0868.
2
DDX4 (DEAD box polypeptide 4) colocalizes with cancer stem cell marker CD133 in ovarian cancers.DDX4(Dead box 多肽 4)与卵巢癌中的癌症干细胞标志物 CD133 共定位。
Biochem Biophys Res Commun. 2014 May 2;447(2):315-22. doi: 10.1016/j.bbrc.2014.03.144. Epub 2014 Apr 13.
3
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.醛脱氢酶与 CD133 联合定义了血管生成性卵巢癌干细胞,预示着患者预后不良。
Cancer Res. 2011 Jun 1;71(11):3991-4001. doi: 10.1158/0008-5472.CAN-10-3175. Epub 2011 Apr 15.
4
[Isolation and identification of cancer stem cells from primary human ovarian cancer tissues].[从原发性人类卵巢癌组织中分离和鉴定癌症干细胞]
Zhonghua Zhong Liu Za Zhi. 2011 Dec;33(12):896-9.
5
Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.64例浆液性卵巢癌病例中CD133和CD117的表达情况
Coll Antropol. 2015 Sep;39(3):745-53.
6
Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.描述人卵巢癌细胞系 OVCAR3 中的 CD133+亚群。
Oncol Rep. 2011 Jan;25(1):141-6.
7
CD133 expression defines a tumor initiating cell population in primary human ovarian cancer.CD133 表达在原发性人卵巢癌中定义了肿瘤起始细胞群体。
Stem Cells. 2009 Dec;27(12):2875-83. doi: 10.1002/stem.236.
8
Identification and characterization of tumorigenic liver cancer stem/progenitor cells.致瘤性肝癌干细胞/祖细胞的鉴定与表征
Gastroenterology. 2007 Jun;132(7):2542-56. doi: 10.1053/j.gastro.2007.04.025. Epub 2007 Apr 15.
9
In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line.在Hep-2细胞系中对CD133作为癌症干细胞假定标志物的体内研究。
Head Neck. 2009 Jan;31(1):94-101. doi: 10.1002/hed.20935.
10
Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors.具有癌干细胞/祖细胞特征的细胞在人类子宫内膜肿瘤中表达CD133抗原。
Clin Cancer Res. 2009 Jul 1;15(13):4299-311. doi: 10.1158/1078-0432.CCR-08-1883. Epub 2009 Jun 9.

引用本文的文献

1
"DEPHENCE" system-a novel regimen of therapy that is urgently needed in the high-grade serous ovarian cancer-a focus on anti-cancer stem cell and anti-tumor microenvironment targeted therapies.“DEPHENCE”系统——一种高级别浆液性卵巢癌迫切需要的新型治疗方案——聚焦于抗癌干细胞和抗肿瘤微环境靶向治疗。
Front Oncol. 2023 Jun 28;13:1201497. doi: 10.3389/fonc.2023.1201497. eCollection 2023.
2
How to win the ovarian cancer stem cell battle: destroying the roots.如何打赢卵巢癌干细胞之战:斩草除根。
Cancer Drug Resist. 2020 Dec 22;3(4):1021-1033. doi: 10.20517/cdr.2020.93. eCollection 2020.
3
Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.
卵巢癌中的癌症干细胞——肿瘤成功的根源和新型治疗的挑战性靶点。
Int J Mol Sci. 2022 Feb 24;23(5):2496. doi: 10.3390/ijms23052496.
4
Carboplatin- and Etoposide-Loaded Lactoferrin Protein Nanoparticles for Targeting Cancer Stem Cells in Retinoblastoma In Vitro.载顺铂和依托泊苷的乳铁蛋白纳米颗粒用于体外靶向视网膜母细胞瘤肿瘤干细胞。
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):13. doi: 10.1167/iovs.62.14.13.
5
Transitional dynamics of cancer stem cells in invasion and metastasis.癌症干细胞在侵袭和转移中的过渡动力学。
Transl Oncol. 2021 Jan;14(1):100909. doi: 10.1016/j.tranon.2020.100909. Epub 2020 Oct 10.
6
Novel Therapeutic Strategies for Ovarian Cancer Stem Cells.卵巢癌干细胞的新型治疗策略
Front Oncol. 2020 Mar 17;10:319. doi: 10.3389/fonc.2020.00319. eCollection 2020.
7
Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex.TGR5 缺乏通过稳定β-连环蛋白破坏复合物加剧免疫介导的胆汁淤积性肝损伤。
Int Immunol. 2020 May 8;32(5):321-334. doi: 10.1093/intimm/dxaa002.
8
Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance.卵巢癌干性:对转移和化疗耐药的生物学及临床意义
Cancers (Basel). 2019 Jun 28;11(7):907. doi: 10.3390/cancers11070907.
9
Ovarian cancer stem cells: still an elusive entity?卵巢癌干细胞:仍是一个难以捉摸的实体?
Mol Cancer. 2017 Mar 20;16(1):64. doi: 10.1186/s12943-017-0638-3.
10
Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.移植受者鳞状细胞癌中供体来源的干细胞与上皮-间质转化
Oncotarget. 2015 Dec 8;6(39):41497-507. doi: 10.18632/oncotarget.6359.